CAS:1431957-73-1
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Array ( [286] => Array ( [id] => 286 [name] => Peptides [url] => category-286-b0.html [cat_desc] => [children] => Array ( [300] => Array ( [id] => 300 [name] => Adrenocorticotropic Hormone/ACTH [url] => category-300-b0.html [cat_desc] => ) [296] => Array ( [id] => 296 [name] => Virus Related Peptides [url] => category-296-b0.html [cat_desc] => ) [760] => Array ( [id] => 760 [name] => Cosmetic Peptides [url] => category-760-b0.html [cat_desc] => ) [292] => Array ( [id] => 292 [name] => Opioid Peptides [url] => category-292-b0.html [cat_desc] => ) [312] => Array ( [id] => 312 [name] => Antimicrobial Peptides [url] => category-312-b0.html [cat_desc] => ) [332] => Array ( [id] => 332 [name] => Cell-Penetrating Peptides [url] => category-332-b0.html [cat_desc] => ) [305] => Array ( [id] => 305 [name] => Amyloid Peptides [url] => category-305-b0.html [cat_desc] => ) [325] => Array ( [id] => 325 [name] => Neuropeptides & Related Peptides [url] => category-325-b0.html [cat_desc] => ) [322] => Array ( [id] => 322 [name] => Other Peptides [url] => category-322-b0.html [cat_desc] => ) [341] => Array ( [id] => 341 [name] => Inflammation Research [url] => category-341-b0.html [cat_desc] => ) [297] => Array ( [id] => 297 [name] => Laminin Peptides [url] => category-297-b0.html [cat_desc] => ) [337] => Array ( [id] => 337 [name] => Cardiovascular Research [url] => category-337-b0.html [cat_desc] => ) [299] => Array ( [id] => 299 [name] => Hormone and Related Peptides [url] => category-299-b0.html [cat_desc] => ) [294] => Array ( [id] => 294 [name] => Cancer Research [url] => category-294-b0.html [cat_desc] => ) [316] => Array ( [id] => 316 [name] => Substrate and Enzyme Inhibitors [url] => category-316-b0.html [cat_desc] => ) [291] => Array ( [id] => 291 [name] => RGD/RAD Peptides [url] => category-291-b0.html [cat_desc] => ) [287] => Array ( [id] => 287 [name] => Substance P & Related Peptides [url] => category-287-b0.html [cat_desc] => ) [307] => Array ( [id] => 307 [name] => Tag Peptides [url] => category-307-b0.html [cat_desc] => ) [304] => Array ( [id] => 304 [name] => Protein Kinases & Related Peptides [url] => category-304-b0.html [cat_desc] => ) ) ) )
CAS:1431957-73-1
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Product Type | Peptides |
CAS | 1431957-73-1 |
Sequence(1LC) | FTISADTSK |
Sequence(3LC) | Phe-Thr-Ile-Ser-Ala-Asp-Thr-Ser-Lys |
Molecular Formula | C42H68N10O16 |
Molecular Weight | 969.06 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Solubility | H2O:50 mg/mL; *Ultrasonic solubilization; |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM). |
In Vitro | undetected |
Reference | [1] Bults P, et al. LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma. Anal Chem. 2016;88(3):1871-1877. |
Unit | Bottle |
Specification | 1mg 5mg |